Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer.
Campbell RA, Wood A, Michael PD, Shin D, Pramod N, Haywood SC, Eltemamy M, Weight C, Haber GP, Lee B, Myles J, McKenney J, Nguyen J, Williamson SR, Przybycin C, Alaghehbandan R, Almassi N.
Campbell RA, et al. Among authors: nguyen j.
Urol Oncol. 2024 Jun 15:S1078-1439(24)00494-0. doi: 10.1016/j.urolonc.2024.05.020. Online ahead of print.
Urol Oncol. 2024.
PMID: 38880703